Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Dou

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|July 9, 2022
The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary InterventionZhi-Fan Li, Shuang Zhang, Hui-Wei Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2019
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formationShujuan Zhang, Jianxiang Zhang, Dongfeng Wei, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndromeHao-Yu Wang, Ran Mo, Chang-Dong Guan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndromeHao-Yu Wang, Ran Mo, Chang-Dong Guan, et al.
Circulation. Cardiovascular Interventions|May 18, 2022
New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational StudyHao-Yu Wang, Ke-Fei Dou, Changdong Guan, et al.
Nature Communications|January 12, 2021
Engineering of a bona fide light-operated calcium channelLian He, Liuqing Wang, Hongxiang Zeng, et al.
Frontiers in Endocrinology|May 16, 2022
Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular DiseaseSha Li, Hui-Hui Liu, Yuan-Lin Guo, et al.
Journal of Translational Medicine|May 26, 2022
Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndromeHui-Hui Liu, Yuan-Lin Guo, Cheng-Gang Zhu, et al.
NPJ Cardiovascular Health|May 4, 2026
Pulse pressure associates with severity and worse outcomes in patients with stable coronary artery diseaseYan Zhang, Sha Li, Hui-Wen Zhang, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|July 9, 2022
The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary InterventionZhi-Fan Li, Shuang Zhang, Hui-Wei Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2019
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formationShujuan Zhang, Jianxiang Zhang, Dongfeng Wei, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndromeHao-Yu Wang, Ran Mo, Chang-Dong Guan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndromeHao-Yu Wang, Ran Mo, Chang-Dong Guan, et al.
Circulation. Cardiovascular Interventions|May 18, 2022
New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational StudyHao-Yu Wang, Ke-Fei Dou, Changdong Guan, et al.
Nature Communications|January 12, 2021
Engineering of a bona fide light-operated calcium channelLian He, Liuqing Wang, Hongxiang Zeng, et al.
Frontiers in Endocrinology|May 16, 2022
Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular DiseaseSha Li, Hui-Hui Liu, Yuan-Lin Guo, et al.
Journal of Translational Medicine|May 26, 2022
Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndromeHui-Hui Liu, Yuan-Lin Guo, Cheng-Gang Zhu, et al.
NPJ Cardiovascular Health|May 4, 2026
Pulse pressure associates with severity and worse outcomes in patients with stable coronary artery diseaseYan Zhang, Sha Li, Hui-Wen Zhang, et al.
Pageof 19